Skip to main content
Premium Trial:

Request an Annual Quote

NorDiag Completes Merger with Genpoint Subsidiary

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norwegian sample preparation firm NorDiag today said it has completed its merger with wholly owned subsidiary Genpoint.

The merger was announced in May as a way to reduce costs to both companies. As part of the transaction, all Genpoint employees are being offered employment with NorDiag, which acquired Genpoint in 2007.

The transaction was carried out with accounting and taxation effect from January 2010, NorDiag said in a statement.

Based in Oslo, NorDiag develops tools for the sample preparation of DNA from difficult biological samples such as stool, urine, and sputum. Genpoint, also based in Oslo, develops and markets nucleic acid sample preparation products for use in DNA-based diagnostics.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.